HOME >> MEDICINE >> NEWS
Rheumatoid arthritis patients can benefit from Enbrel in combination with methotrexate

eadaches (17%) Malignancies were rare.

Physicians in Europe have become familiar with the benefits and long-term tolerability profile of ENBREL since it became commercially available over six years ago. More than 400,000 patients have been treated worldwide across indications. ENBREL acts by binding tumor necrosis factor (TNF), one of the dominant inflammatory cytokines or regulatory proteins that play an important role in both normal immune function and the cascade of reactions that causes the inflammatory processes of rheumatoid arthritis. The binding of ENBREL to TNF renders the bound TNF biologically inactive, which can result in significant reduction in inflammatory activity.


'"/>

Contact: Jes Lauritzen
jes.lauritzen@ketchum.com
44-781-437-7386
Ketchum
22-Jun-2006


Page: 1 2 3 4 5

Related medicine news :

1. Rheumatoid arthritis and sex differences
2. Rheumatoid arthritis can be prevented if the timing is right
3. Rheumatoid arthritis drug linked to serious infections and cancers
4. Rheumatoid arthritis does not increase risk of hearing loss, Mayo Clinic study finds
5. Rheumatoid arthritis patients are more at risk of coronary artery disease
6. Using coxibs and NSAIDs to treat osteoarthritis
7. Experimental gene therapy abolishes arthritis pain and lessens joint damage
8. Counseling, coping skills could reduce arthritis disability
9. Green tea compound suppresses factors causing cartilage, bone destruction in arthritis
10. Green tea compound may be a therapy for people with rheumatoid arthritis
11. Costs of treating arthritis on the rise nationwide, study finds

Post Your Comments:
(Date:7/7/2015)... ... July 07, 2015 , ... ... strong managerial expertise to oversee large healthcare operations and their success is ... partners, insurance companies, and regulators. American Sentinel University, an innovative, accredited provider ...
(Date:7/7/2015)... ... July 07, 2015 , ... On May 29, 2015, Health Canada ... the use of gluten-free claims for gluten free oats and foods that contain them ... Gluten-Free Certification Program (GFCP) to include gluten-free oat products in Canada,” says Frank ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... today announced they have been selected by the Department of Vermont Health Access ... its Medicaid Management Information System (MMIS) and Integrated Contact Center System project. , ...
(Date:7/6/2015)... ... July 06, 2015 , ... Human induced pluripotent ... iPSCs are generated from adult cells, such as blood or skin, can replicate ... human body. , iPSC-derived cardiomyocytes have proven valuable in helping ...
(Date:7/6/2015)... ... July 06, 2015 , ... University of Pittsburgh Cancer Institute ... thyroid cancer testing to reflect newly available tests that better incorporate personalized medicine into ... to interpret thyroid cancer tests is published in the July issue of the scientific ...
Breaking Medicine News(10 mins):Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 2Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 3Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 4Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 2Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 3Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 4Health News:CSG Government Solutions Selected by the Department of Vermont Health Access to Provide Quality Assurance and Independent Verification and Validation Services 2Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 2Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 3Health News:Cellular Dynamics’ Webinar Underscores the Value of Using Human iPSC-derived Cardiomyocytes for Investigative in vitro Drug Toxicology 4Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 2Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 3Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 4Health News:Pitt Scientists Lead Consensus Guidelines for Thyroid Cancer Molecular Tests 5
(Date:7/6/2015)... 6, 2015  Impax Laboratories, Inc. (NASDAQ: IPXL ... second quarter 2015 financial results on Monday, August 10, ... markets. The Company will host a conference call and ... Eastern Time on August 10, 2015. The ... the Investor Relations section of the Company,s Web site ...
(Date:7/6/2015)... HORSHAM, Pa. , July 6, 2015 /PRNewswire/ ... procedure-based, bone fixation concept the FlowerCube™, announced today ... approval opens the opportunity for significant expansion of ...   The approval encompasses Flower Orthopedics, ... fixation solutions for upper and lower extremities. Consisting ...
(Date:7/6/2015)... NEWTOWN, Pa. , July 6, 2015 /PRNewswire/ ... services and technology provider, today announced that it ... retention firm, MediciGroup ® , Inc. (Medici).  The ... Access to Patients, LLC.  Medici also provides a ... finds missing patients globally.  Together with Medici, ...
Breaking Medicine Technology:Impax to Report Second Quarter 2015 Results on August 10, 2015 2Flower Orthopedics cleared to enter the European Union 2BioClinica Acquires MediciGroup 2BioClinica Acquires MediciGroup 3
Cached News: